Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Risk factors for brain tumors

Dominique Michaud, Sc.D
Tracy Batchelor, MD, MPH
Section Editors
Jay S Loeffler, MD
Patrick Y Wen, MD
Deputy Editor
April F Eichler, MD, MPH


Primary brain tumors are a diverse group of neoplasms arising from different cells of the central nervous system (CNS). (See "Classification and pathologic diagnosis of gliomas", section on 'Histopathologic and molecular classification'.)

Although incidence rates for primary brain and central nervous system cancers were increasing through the late 1980s, the rates have been decreasing by approximately 0.2 percent annually over the past 15 years [1]. Among the factors that contributed to the early increase in rates were the introduction of noninvasive diagnostic technology including computerized tomography (CT) in the 1970s and magnetic resonance imaging (MRI) in the 1980s, better health care access for older adults [2]. (See "Incidence of primary brain tumors".)

These data, in conjunction with evidence suggesting the increase may have been occurring for many decades, leave open the possibility that environmental exposures may account for the increasing incidence of brain tumors.  

General risk factors that have been associated with brain tumors are discussed here. A number of putative risk factors for brain tumors have been examined (table 1). A shortcoming in many reports is the tendency to group all brain tumors together; this approach may miss important exposures for specific histopathologic types of tumors [3].

The epidemiology of meningioma and its associated risk factors are discussed separately. (See "Epidemiology, pathology, clinical features, and diagnosis of meningioma".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 18, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Studies Review, 1975-2012, National Cancer Institute, Bethesda 2015.
  2. Polednak AP. Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1988. Neuroepidemiology 1996; 15:51.
  3. Davis FG, Preston-Martin S. Epidemiology. In: Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th ed, Bigner DD, McLendon RE, Bruner JM (Eds), Arnold, London 1998.
  4. Braganza MZ, Kitahara CM, Berrington de González A, et al. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol 2012; 14:1316.
  5. Bowers DC, Nathan PC, Constine L, et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 2013; 14:e321.
  6. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006; 98:1528.
  7. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354:34.
  8. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.
  9. Davis F, Il'yasova D, Rankin K, et al. Medical diagnostic radiation exposures and risk of gliomas. Radiat Res 2011; 175:790.
  10. Wertheimer N, Leeper E. Electrical wiring configurations and childhood cancer. Am J Epidemiol 1979; 109:273.
  11. Preston-Martin S, Mack WJ. Neoplasms of the nervous system. In: Cancer Epidemiology and Prevention, 2nd ed, Shottenfeld D, Fraumeni JF (Eds), Oxford University Press, New York 1996.
  12. NIEHS. Health effects from exposure to power-line frequency electric and magnetic fields. NIH publication no 99-4493, National Institute of Environmental Health Sciences; 1999.
  13. Kheifets LI, Sussman SS, Preston-Martin S. Childhood brain tumors and residential electromagnetic fields (EMF). Rev Environ Contam Toxicol 1999; 159:111.
  14. Preston-Martin S, Navidi W, Thomas D, et al. Los Angeles study of residential magnetic fields and childhood brain tumors. Am J Epidemiol 1996; 143:105.
  15. Gurney JG, Mueller BA, Davis S, et al. Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use. Am J Epidemiol 1996; 143:120.
  16. Sorahan T, Hamilton L, Gardiner K, et al. Maternal occupational exposure to electromagnetic fields before, during, and after pregnancy in relation to risks of childhood cancers: findings from the Oxford Survey of Childhood Cancers, 1953-1981 deaths. Am J Ind Med 1999; 35:348.
  17. Coble JB, Dosemeci M, Stewart PA, et al. Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol 2009; 11:242.
  18. Rothman KJ, Chou CK, Morgan R, et al. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology 1996; 7:291.
  19. Myung SK, Ju W, McDonnell DD, et al. Mobile phone use and risk of tumors: a meta-analysis. J Clin Oncol 2009; 27:5565.
  20. Corle C, Makale M, Kesari S. Cell phones and glioma risk: a review of the evidence. J Neurooncol 2012; 106:1.
  21. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. In: IARC monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon Vol 102.
  22. Little MP, Rajaraman P, Curtis RE, et al. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ 2012; 344:e1147.
  23. Deltour I, Auvinen A, Feychting M, et al. Mobile phone use and incidence of glioma in the Nordic countries 1979-2008: consistency check. Epidemiology 2012; 23:301.
  24. Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology 1989; 8:283.
  25. McLaughlin JK, Malker HS, Blot WJ, et al. Occupational risks for intracranial gliomas in Sweden. J Natl Cancer Inst 1987; 78:253.
  26. Wong O, Raabe GK. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am J Ind Med 1989; 15:283.
  27. Musicco M, Sant M, Molinari S, et al. A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol 1988; 128:778.
  28. Littorin M, Attewell R, Skerfving S, et al. Mortality and tumour morbidity among Swedish market gardeners and orchardists. Int Arch Occup Environ Health 1993; 65:163.
  29. Heineman EF, Gao YT, Dosemeci M, McLaughlin JK. Occupational risk factors for brain tumors among women in Shanghai, China. J Occup Environ Med 1995; 37:288.
  30. Khuder SA, Mutgi AB, Schaub EA. Meta-analyses of brain cancer and farming. Am J Ind Med 1998; 34:252.
  31. Piel C, Pouchieu C, Tual S, et al. Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN. Int J Cancer 2017; 141:1771.
  32. Borak J, Slade MD, Russi M. Risks of brain tumors in rubber workers: a metaanalysis. J Occup Environ Med 2005; 47:294.
  33. International Agency for Research on Cancer. Occupational exposures in petroleum refining; crude oil and major petroleum fuels. In: IARC Monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon 1989. Vol 45.
  34. Wong O, Raabe GK. A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350,000 workers. Regul Toxicol Pharmacol 2000; 32:78.
  35. Lin RS, Dischinger PC, Conde J, Farrell KP. Occupational exposure to electromagnetic fields and the occurrence of brain tumors. An analysis of possible associations. J Occup Med 1985; 27:413.
  36. Thomas TL, Stolley PD, Stemhagen A, et al. Brain tumor mortality risk among men with electrical and electronics jobs: a case-control study. J Natl Cancer Inst 1987; 79:233.
  37. Loomis DP, Savitz DA. Mortality from brain cancer and leukaemia among electrical workers. Br J Ind Med 1990; 47:633.
  38. Juutilainen J, Läärä E, Pukkala E. Incidence of leukaemia and brain tumours in Finnish workers exposed to ELF magnetic fields. Int Arch Occup Environ Health 1990; 62:289.
  39. Schlehofer B, Kunze S, Sachsenheimer W, et al. Occupational risk factors for brain tumors: results from a population-based case-control study in Germany. Cancer Causes Control 1990; 1:209.
  40. Bates MN. Extremely low frequency electromagnetic fields and cancer: the epidemiologic evidence. Environ Health Perspect 1991; 95:147.
  41. Savitz DA, Loomis DP. Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol 1995; 141:123.
  42. Sahl JD, Kelsh MA, Greenland S. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology 1993; 4:104.
  43. Cushing H. The meningiomas (dural endotheliomas). Their source and favored seats of origin. Brain 1922; 45:282.
  44. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 1998; 9:109.
  45. Choi NW, Schuman LM, Gullen WH. Epidemiology of primary central nervous system neoplasms. II. Case-control study. Am J Epidemiol 1970; 91:467.
  46. Wrensch M, Miike R, Lee M, Neuhaus J. Are prior head injuries or diagnostic X-rays associated with glioma in adults? The effects of control selection bias. Neuroepidemiology 2000; 19:234.
  47. Burch JD, Craib KJ, Choi BC, et al. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987; 78:601.
  48. Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985. Br J Cancer 1989; 59:783.
  49. Ryals BM, Rubel EW. Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science 1988; 240:1774.
  50. Hamernik RP, Turrentine G, Roberto M, et al. Anatomical correlates of impulse noise-induced mechanical damage in the cochlea. Hear Res 1984; 13:229.
  51. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999; 82:155.
  52. Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99:252.
  53. Wiemels JL, Wiencke JK, Sison JD, et al. History of allergies among adults with glioma and controls. Int J Cancer 2002; 98:609.
  54. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, et al. History of allergies and risk of glioma in adults. Int J Cancer 2006; 119:2165.
  55. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007; 99:1544.
  56. Wiemels JL, Wiencke JK, Patoka J, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004; 64:8468.
  57. Calboli FC, Cox DG, Buring JE, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst 2011; 103:1588.
  58. Schwartzbaum J, Ding B, Johannesen TB, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 2012; 104:1251.
  59. Schlehofer B, Siegmund B, Linseisen J, et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy 2011; 66:1434.
  60. National Research Council. The health effects of nitrate, nitrite, and N-nitroso compounds. Part 1. National Academy Press; Washington DC.
  61. Chen H, Ward MH, Tucker KL, et al. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 2002; 13:647.
  62. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997; 8:13.
  63. Giles GG, McNeil JJ, Donnan G, et al. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994; 59:357.
  64. Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. IARC Sci Publ 1991; :197.
  65. Huncharek M, Kupelnick B, Wheeler L. Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 2003; 22:129.
  66. Dubrow R, Darefsky AS, Park Y, et al. Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev 2010; 19:1709.
  67. Michaud DS, Holick CN, Batchelor TT, et al. Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am J Clin Nutr 2009; 90:570.
  68. McCredie M, Maisonneuve P, Boyle P. Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994; 56:11.
  69. Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl 1998; 11:17.
  70. Bunin GR, Kuijten RR, Buckley JD, et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993; 329:536.
  71. Ahlbom A, Navier IL, Norell S, et al. Nonoccupational risk indicators for astrocytomas in adults. Am J Epidemiol 1986; 124:334.
  72. Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control 1997; 8:5.
  73. Hu J, La Vecchia C, Negri E, et al. Diet and brain cancer in adults: a case-control study in northeast China. Int J Cancer 1999; 81:20.
  74. Boeing H, Schlehofer B, Blettner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. Int J Cancer 1993; 53:561.
  75. Kaplan S, Novikov I, Modan B. Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol. Am J Epidemiol 1997; 146:832.
  76. Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of intake of fruit, vegetables, and carotenoids and the risk of adult glioma. Am J Clin Nutr 2007; 85:877.
  77. Hurley SF, McNeil JJ, Donnan GA, et al. Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health 1996; 50:442.
  78. Filippini G, Maisonneuve P, McCredie M, et al. Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Surveillance of Environmental Aspects Related to Cancer in Humans. Int J Cancer 2002; 100:206.
  79. Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer 2006; 118:1848.
  80. Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol 2007; 9:326.
  81. Milne E, Greenop KR, Scott RJ, et al. Parental smoking and risk of childhood brain tumors. Int J Cancer 2013; 133:253.
  82. Preston-Martin S, Yu MC, Henderson BE, Roberts C. Risk factors for meningiomas in men in Los Angeles County. J Natl Cancer Inst 1983; 70:863.
  83. Galeone C, Malerba S, Rota M, et al. A meta-analysis of alcohol consumption and the risk of brain tumours. Ann Oncol 2013; 24:514.
  84. Ward DW, Mattison ML, Finn R. Association between Previous Tuberculous Infection and Cerebal Glioma. Br Med J 1973; 1:83.
  85. Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989; 49:6130.
  86. Huang H, Reis R, Yonekawa Y, et al. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 1999; 9:33.
  87. Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998; 279:292.
  88. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95:532.
  89. Strickler HD, Goedert JJ. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence. Dev Biol Stand 1998; 94:235.
  90. Rollison DE, Helzlsouer KJ, Alberg AJ, et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 2003; 12:460.
  91. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347.
  92. Mitchell DA, Xie W, Schmittling R, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008; 10:10.
  93. Sabatier J, Uro-Coste E, Pommepuy I, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 2005; 92:747.
  94. Lau SK, Chen YY, Chen WG, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005; 18:838.
  95. Holdhoff M, Guner G, Rodriguez FJ, et al. Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. Clin Cancer Res 2017; 23:3150.
  96. Taha MS, Abdalhamid BA, El-Badawy SA, et al. Expression of cytomegalovirus in glioblastoma multiforme: Myth or reality? Br J Neurosurg 2016; 30:307.
  97. Linet MS, Gridley G, Cnattingius S, et al. Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control 1996; 7:437.
  98. Linos A, Kardara M, Kosmidis H, et al. Reported influenza in pregnancy and childhood tumour. Eur J Epidemiol 1998; 14:471.
  99. Adelstein AM, Donovan JW. Malignant disease in children whose mothers had chickenpox, mumps, or rubella in pregnancy. Br Med J 1972; 4:629.
  100. Wrensch M, Weinberg A, Wiencke J, et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am J Epidemiol 2005; 161:929.
  101. Scheurer ME, El-Zein R, Thompson PA, et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev 2008; 17:1277.
  102. Schuman LM, Choi NW, Gullen WH. Relationship of central nervous system neoplasms to Toxoplasma gondii infection. Am J Public Health Nations Health 1967; 57:848.
  103. Ryan P, Hurley SF, Johnson AM, et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol 1993; 22:412.
  104. Bondy ML, Lustbader ED, Buffler PA, et al. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991; 8:253.
  105. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995; 11:90.
  106. Cichowski K, Shih TS, Schmitt E, et al. Mouse models of tumor development in neurofibromatosis type 1. Science 1999; 286:2172.
  107. Vogel KS, Klesse LJ, Velasco-Miguel S, et al. Mouse tumor model for neurofibromatosis type 1. Science 1999; 286:2176.
  108. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363:515.
  109. Scoles DR, Huynh DP, Morcos PA, et al. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat Genet 1998; 18:354.
  110. Bruder CE, Ichimura K, Blennow E, et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene? Genes Chromosomes Cancer 1999; 25:184.
  111. Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol 2010; 99:341.
  112. Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84:603.
  113. Perry A, Giannini C, Raghavan R, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 2001; 60:994.
  114. Larson JJ, van Loveren HR, Balko MG, Tew JM Jr. Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 1995; 83:596.
  115. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332:839.
  116. Stark Z, Campbell LJ, Mitchell C, et al. Clinical problem-solving. Spot diagnosis. N Engl J Med 2014; 370:2229.
  117. Bruwer Z, Algar U, Vorster A, et al. Predictive genetic testing in children: constitutional mismatch repair deficiency cancer predisposing syndrome. J Genet Couns 2014; 23:147.
  118. Bouffet E, Larouche V, Campbell BB, et al. Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. J Clin Oncol 2016; 34:2206.
  119. Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997; 145:581.
  120. Malmer B, Grönberg H, Bergenheim AT, et al. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999; 81:366.
  121. Blumenthal DT, Cannon-Albright LA. Familiality in brain tumors. Neurology 2008; 71:1015.
  122. Malmer B, Iselius L, Holmberg E, et al. Genetic epidemiology of glioma. Br J Cancer 2001; 84:429.
  123. Sadetzki S, Bruchim R, Oberman B, et al. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer 2013; 49:1335.
  124. Bainbridge MN, Armstrong GN, Gramatges MM, et al. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst 2015; 107:384.
  125. Robles-Espinoza CD, Harland M, Ramsay AJ, et al. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 2014; 46:478.
  126. Shi J, Yang XR, Ballew B, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet 2014; 46:482.
  127. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41:899.
  128. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009; 41:905.
  129. Rajaraman P, Melin BS, Wang Z, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet 2012; 131:1877.
  130. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011; 20:2897.
  131. Dobbins SE, Broderick P, Melin B, et al. Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 2011; 43:825.
  132. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics 2009; 6:427.
  133. Jiang J, Quan XF, Zhang L, Wang YC. The XRCC3 Thr241Met polymorphism influences glioma risk - a meta-analysis. Asian Pac J Cancer Prev 2013; 14:3169.
  134. Backes DM, Siddiq A, Cox DG, et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol 2013; 113:229.
  135. Schwartzbaum J, Ahlbom A, Malmer B, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2005; 65:6459.
  136. Amirian E, Liu Y, Scheurer ME, et al. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol 2010; 12:444.
  137. Wiemels JL, Wiencke JK, Kelsey KT, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007; 16:1229.
  138. Michaud DS, Siddiq A, Cox DG, et al. Mannose-binding lectin 2 gene and risk of adult glioma. PLoS One 2013; 8:e61117.